Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VesCell in critical limb ischemia
NCT01584986Phase 2Completed
- Sponsor
- Salus
- Start
- May 2008
- Primary completion
- Apr 2009
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous angiogenic cell precursors in critical limb ischemia (CLI), sponsored by Salus. Started May 2008; status: completed.
02
Drugs
autologous angiogenic cell precursors
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT01584986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01584986.